This map shows the geographic impact of H Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Jaeger more than expected).
This network shows the impact of papers produced by H Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Jaeger. The network helps show where H Jaeger may publish in the future.
Co-authorship network of co-authors of H Jaeger
This figure shows the co-authorship network connecting the top 25 collaborators of H Jaeger.
A scholar is included among the top collaborators of H Jaeger based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H Jaeger. H Jaeger is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Pabst, G, et al.. (1995). [The pharmacokinetics and bioavailability of a new mexiletine preparation in healthy volunteers].. PubMed. 45(3). 254–7.1 indexed citations
2.
Bonn, R., et al.. (1995). Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers.. PubMed. 45(2). 142–5.8 indexed citations
Kappler, John W., et al.. (1993). Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers.. PubMed. 43(7). 737–43.2 indexed citations
Neugebauer, G., et al.. (1989). Performance of a slow-release formulation of isosorbide-5-mononitrate (ISMO retard).. PubMed. 27(1). 34–8.2 indexed citations
Jaeger, H, et al.. (1988). Determination of flurazepam and its major metabolites N-1-hydroxyethyl- and N-1-desalkylflurazepam in plasma by capillary gas chromatography.. PubMed. 38(3). 400–3.1 indexed citations
11.
Jaeger, H, et al.. (1988). Gas chromatographic/mass spectrometric determination of clonidine in body fluids. Application to pharmacokinetics.. PubMed. 38(3). 404–7.1 indexed citations
12.
Nieder, Matthew, et al.. (1986). [The pharmacokinetics and bioavailability of urapidil. In vitro/in vivo correlations of different experimental formulations].. PubMed. 36(8). 1265–7.1 indexed citations
13.
Jaeger, H. (1985). Glass capillary chromatography in clinical medicine and pharmacology.13 indexed citations
14.
Pabst, G, et al.. (1985). [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].. PubMed. 35(12). 1840–2.1 indexed citations
Jaeger, H, et al.. (1985). [The bioavailability and pharmacokinetics of two carbocysteine preparations after single and multiple dosing].. PubMed. 35(1). 163–6.4 indexed citations
Nieder, Matthew, et al.. (1983). [Comparative studies on the in vitro dissolution and bioavailability of various acetylsalicylic acid preparations].. PubMed. 33(3). 439–45.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.